Form DEFA14A CHINOOK THERAPEUTICS,
Tweet
Share
E-mail
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement | |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
| ☐ | Definitive Proxy Statement | |
| ☒ | Definitive Additional Materials | |
| ☐ | Soliciting Material Pursuant to §240.14a-12 | |
CHINOOK THERAPEUTICS, INC.
(Name of Registrant as Specified In Its Charter)
N/A
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. | |||
| ☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||
| 1) | Title of each class of securities to which transaction applies:
| |||
| 2) | Aggregate number of securities to which transaction applies:
| |||
| 3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
| |||
| 4) | Proposed maximum aggregate value of transaction:
| |||
| 5) | Total fee paid:
| |||
| ☐ | Fee paid previously with preliminary materials. | |||
| ☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |||
| 1) | Amount Previously Paid:
| |||
| 2) | Form, Schedule or Registration Statement No.:
| |||
| 3) | Filing Party:
| |||
| 4) | Date Filed:
| |||
Your Vote Counts! CHINOOK THERAPEUTICS INC 2021 Annual Meeting Vote by June 03, 2021 11 :59 PM ET
CHINOOK THERAPEUTICS INC 1600 FAIRVIEW AVE E SUITE #100 SEATILE, WA 98102
You invested in CHINOOK THERAPEUTICS INC and it•s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an
important notice regarding the availability of proxy material for the shareholder meeting to be held on June 04, 2021. Get informed before you vote View the Annual Report, Notice & Proxy Statement online OR you can receive a free paper or
email copy of the material(s) by requesting prior to May 21, 2021. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number
(indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. paper or email copy. Smartphone users Vote Virtually at the Meeting* Point your camera here and June 04, 2021 8:00AM PDT vote without
entering a ~Inumber Virtually at: www.virtualshareholdermeeting.com/KDNY2021
*Please check the meeting materials for any special requirements for meeting
attendance.
Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder
meeting. Please follow the instructions on the reverse side to vote these important matters. Board Voting Items Recommends 1. Election of Directors Nominees: 0 For 01) Srinivas Akkaraju 02) Dolca Thomas 2. Ratify the appointment of
PricewaterhouseCoopers LLP as the Company’s independent registered public accounting OF firm for the fiscal year ending December 31, 2021. or 3. Advisory vote on the compensation of the Company’s named executive officers. 0 For 4. Non-binding vote on an annual advisory vote on the compensation of the Company’s named executive officers. 0 Year NOTE: Such other business as may properly come before the meeting or any adjournment thereof.
Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Sign up forE-delivery”.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NBA LEGEND UDONIS HASLEM UNVEILS FORTY OG CANNABIS STRAIN
- ROSEN, THE FIRST FILING FIRM, Encourages Sonder Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – SOND
- EY Announces Spark Biomedical CEO Daniel Powell as an Entrepreneur Of The Year® 2024 Southwest Award Finalist
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
